Press Releases from Ovarian Cancer (7 total)
Ovarian Cancer - Identifying and Commercializing First-in-Class Innovation: Fron …
Researchmoz added Most up-to-date research on "Ovarian Cancer - Identifying and Commercializing First-in-Class Innovation: Frontier Pharma" to its huge collection of research reports.
Ovarian cancer is the sixth most common cancer in females and it also has the highest mortality rate of gynecological cancers. The five-year survival rate is approximately 45%, although the disease is ultimately fatal in the majority of patients due to a high rate of recurrence. Surgery is…
Ovarian Cancer - US Market Insights, Epidemiology and Market Forecast-2020
ALBANY, NY, April 6, 2017 : DelveInsights Ovarian Cancer - Market Insights, Epidemiology and Market Forecast-2020- US Reports provides an overview of the disease and global market size of the Ovarian Cancer for the United States. It also includes global historical and forecasted epidemiological data for the diagnosed incident cases of Ovarian Cancer from 2012-2020. According to DelveInsight, the forecasted patient population of Ovarian cancer will decrease at a CAGR…
Recent Study on Ovarian Cancer Identifying and Commercializing First-in-Class In …
Researchmoz added Most up-to-date research on "Frontier Pharma: Ovarian Cancer - Identifying and Commercializing First-in-Class Innovation" to its huge collection of research reports.
Ovarian cancer is the sixth most common cancer in females and it also has the highest mortality rate of gynecological cancers. The five-year survival rate is approximately 45%, although the disease is ultimately fatal in the majority of patients due to a high rate of recurrence. Surgery is…
Therapeutics Development For Ovarian Cancer - Pipeline Insights, 2017
Researchmoz added Most up-to-date research on "Therapeutics Development For Ovarian Cancer - Pipeline Insights, 2017" to its huge collection of research reports.
DelveInsights, Ovarian Cancer -Pipeline Insights, 2016, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under the category of Ovarian Cancer. Ovarian cancer is the sudden growth of the cells…
Global Historical And Forecasted Epidemiological Data For Diagnosed Incident Cas …
ResearchMoz presents this most up-to-date research on "Global Historical And Forecasted Epidemiological Data For Diagnosed Incident Cases Of Ovarian Cancer From 2017 - 2020".
DelveInsights Ovarian Cancer - Market Insights, Epidemiology and Market Forecast-2020- US Reports provides an overview of the disease and global market size of the Ovarian Cancer for the United States. It also includes global historical and forecasted epidemiological data for the diagnosed incident cases of Ovarian Cancer…
Ovarian Cancer - Heat Map and Analysis
Albany, NY, Feb 27, 2017: Ovarian Cancer (OC) is the fifth most common malignancy diagnosed in women, and the most common gynecological cancer, with an estimated 225,000 new cases diagnosed globally in 2008. Rates are particularly high in developed countries, and especially in Northern Europe. However, substantial improvements in the treatment of OC have been made in recent decades, through the introduction of platinum-based compounds, and improvements in surgery.
This has…
Ovarian Cancer - Pipeline Review, H2 2016, Pharmaceutical and Healthcare
"Ovarian Cancer - Pipeline Review, H2 2016" The Report covers current Market Trends, Worldwide Analysis, Global Forecast, Review, Share, Size, Growth, Effect.
Description-
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ovarian Cancer Pipeline Review, H2 2016, provides an overview of the Ovarian Cancer (Oncology) pipeline landscape.
Ovarian cancer is any cancerous growth that may occur in different parts of the ovary. The majority of ovarian cancers arise from the epithelium…
